Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 843

1.

Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report.

Elliott PM, Anastasakis A, Asimaki A, Basso C, Bauce B, Brooke MA, Calkins H, Corrado D, Duru F, Green KJ, Judge DP, Kelsell D, Lambiase PD, McKenna WJ, Pilichou K, Protonotarios A, Saffitz JE, Syrris P, Tandri H, Te Riele A, Thiene G, Tsatsopoulou A, van Tintelen JP.

Eur J Heart Fail. 2019 Jun 18. doi: 10.1002/ejhf.1534. [Epub ahead of print]

PMID:
31210398
2.

Understanding the Myocardial Architecture of Hypertrophic Cardiomyopathy for Clinical Care.

McKenna WJ, Moon JC, Sulaiman A.

J Am Coll Cardiol. 2019 May 28;73(20):2503-2505. doi: 10.1016/j.jacc.2019.03.466. No abstract available.

PMID:
31118143
3.

Risk score for the exclusion of arrhythmic events in arrhythmogenic right ventricular cardiomyopathy at first presentation.

Vischer AS, Castelletti S, Syrris P, Bastiaenen R, Miles C, Akdis D, Denhaerynck K, Jacoby D, Saguner AM, Krahn AD, Behr ER, McKenna WJ, Pantazis A.

Int J Cardiol. 2019 Sep 1;290:100-105. doi: 10.1016/j.ijcard.2019.04.090. Epub 2019 May 1.

PMID:
31104822
4.

2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy.

Towbin JA, McKenna WJ, Abrams DJ, Ackerman MJ, Calkins H, Darrieux FCC, Daubert JP, de Chillou C, DePasquale EC, Desai MY, Estes NAM 3rd, Hua W, Indik JH, Ingles J, James CA, John RM, Judge DP, Keegan R, Krahn AD, Link MS, Marcus FI, McLeod CJ, Mestroni L, Priori SG, Saffitz JE, Sanatani S, Shimizu W, van Tintelen JP, Wilde AAM, Zareba W.

Heart Rhythm. 2019 May 9. pii: S1547-5271(19)30438-2. doi: 10.1016/j.hrthm.2019.05.007. [Epub ahead of print]

PMID:
31078652
5.

Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinoma.

McGowan DR, Skwarski M, Bradley KM, Campo L, Fenwick JD, Gleeson FV, Green M, Horne A, Maughan TS, McCole MG, Mohammed S, Muschel RJ, Ng SM, Panakis N, Prevo R, Strauss VY, Stuart R, Tacconi EMC, Vallis KA, McKenna WG, Macpherson RE, Higgins GS.

Eur J Cancer. 2019 May;113:87-95. doi: 10.1016/j.ejca.2019.03.015. Epub 2019 Apr 13.

6.

Prediction of ventricular arrhythmia and sudden death in arrhythmogenic right ventricular cardiomyopathy.

McKenna WJ, Asaad NA, Jacoby DL.

Eur Heart J. 2019 Jun 14;40(23):1859-1861. doi: 10.1093/eurheartj/ehz195. No abstract available.

PMID:
30977786
7.

Heart failure in patients with arrhythmogenic right ventricular cardiomyopathy: Genetic characteristics.

Vischer AS, Castelletti S, Syrris P, McKenna WJ, Pantazis A.

Int J Cardiol. 2019 Jul 1;286:99-103. doi: 10.1016/j.ijcard.2019.01.065. Epub 2019 Jan 27.

PMID:
30765282
8.

Effect of Trimetazidine Dihydrochloride Therapy on Exercise Capacity in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A Randomized Clinical Trial.

Coats CJ, Pavlou M, Watkinson OT, Protonotarios A, Moss L, Hyland R, Rantell K, Pantazis AA, Tome M, McKenna WJ, Frenneaux MP, Omar R, Elliott PM.

JAMA Cardiol. 2019 Feb 6. doi: 10.1001/jamacardio.2018.4847. [Epub ahead of print]

PMID:
30725091
9.

Reasons for delayed antiretroviral therapy (ART) initiation in the era of early ART initiation guidelines: a retrospective service evaluation.

Lee MJ, Venturelli S, McKenna W, Teh J, Negedu O, Florman KE, Musbahi E, Bailey AC, Mackie NE, Fox J, Fidler S.

Int J STD AIDS. 2019 Mar;30(4):415-418. doi: 10.1177/0956462418814985. Epub 2019 Jan 8.

PMID:
30621548
10.

Proteomic Analysis of the Myocardium in Hypertrophic Obstructive Cardiomyopathy.

Coats CJ, Heywood WE, Virasami A, Ashrafi N, Syrris P, Dos Remedios C, Treibel TA, Moon JC, Lopes LR, McGregor CGA, Ashworth M, Sebire NJ, McKenna WJ, Mills K, Elliott PM.

Circ Genom Precis Med. 2018 Dec;11(12):e001974. doi: 10.1161/CIRCGEN.117.001974.

PMID:
30562113
11.

Lamin mutation location predicts cardiac phenotype severity: combined analysis of the published literature.

Captur G, Arbustini E, Syrris P, Radenkovic D, O'Brien B, Mckenna WJ, Moon JC.

Open Heart. 2018 Oct 25;5(2):e000915. doi: 10.1136/openhrt-2018-000915. eCollection 2018.

12.

Loss-of-function desmoplakin I and II mutations underlie dominant arrhythmogenic cardiomyopathy with a hair and skin phenotype.

Maruthappu T, Posafalvi A, Castelletti S, Delaney PJ, Syrris P, O'Toole EA, Green KJ, Elliott PM, Lambiase PD, Tinker A, McKenna WJ, Kelsell DP.

Br J Dermatol. 2019 May;180(5):1114-1122. doi: 10.1111/bjd.17388. Epub 2019 Jan 2.

PMID:
30382575
13.

Ablation compared with drug therapy for recurrent ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: Results from a multicenter study.

Mahida S, Venlet J, Saguner AM, Kumar S, Baldinger SH, AbdelWahab A, Tedrow UB, Castelletti S, Pantazis A, John RM, McKenna WJ, Lambiase PD, Duru F, Sapp JL, Zeppenfeld K, Stevenson WG.

Heart Rhythm. 2019 Apr;16(4):536-543. doi: 10.1016/j.hrthm.2018.10.016. Epub 2018 Oct 24.

PMID:
30366162
14.

Ethnic differences in out-of-hospital cardiac arrest among Middle Eastern Arabs and North African populations living in Qatar.

Irfan FB, Castren M, Bhutta ZA, George P, Qureshi I, Thomas SH, Pathan SA, Alinier G, Shaikh LA, Suwaidi JA, Singh R, Shuaib A, Tariq T, McKenna WJ, Cameron PA, Djarv T.

Ethn Health. 2018 Oct 10:1-10. doi: 10.1080/13557858.2018.1530736. [Epub ahead of print]

PMID:
30303400
15.

A handheld platform for target protein detection and quantification using disposable nanopore strips.

Morin TJ, McKenna WL, Shropshire TD, Wride DA, Deschamps JD, Liu X, Stamm R, Wang H, Dunbar WB.

Sci Rep. 2018 Oct 4;8(1):14834. doi: 10.1038/s41598-018-33086-7.

16.

No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathy.

Hoorntje ET, Posafalvi A, Syrris P, van der Velde KJ, Bolling MC, Protonotarios A, Boven LG, Amat-Codina N, Groeneweg JA, Wilde AA, Sobreira N, Calkins H, Hauer RNW, Jonkman MF, McKenna WJ, Elliott PM, Sinke RJ, van den Berg MP, Chelko SP, James CA, van Tintelen JP, Judge DP, Jongbloed JDH.

PLoS One. 2018 Aug 30;13(8):e0203078. doi: 10.1371/journal.pone.0203078. eCollection 2018.

17.

CDK1 inhibition sensitizes normal cells to DNA damage in a cell cycle dependent manner.

Prevo R, Pirovano G, Puliyadi R, Herbert KJ, Rodriguez-Berriguete G, O'Docherty A, Greaves W, McKenna WG, Higgins GS.

Cell Cycle. 2018;17(12):1513-1523. doi: 10.1080/15384101.2018.1491236. Epub 2018 Jul 25.

PMID:
30045664
18.

Nucleoporin 54 contributes to homologous recombination repair and post-replicative DNA integrity.

Rodriguez-Berriguete G, Granata G, Puliyadi R, Tiwana G, Prevo R, Wilson RS, Yu S, Buffa F, Humphrey TC, McKenna WG, Higgins GS.

Nucleic Acids Res. 2018 Sep 6;46(15):7731-7746. doi: 10.1093/nar/gky569.

19.

Frequency of genetic variants associated with arrhythmogenic right ventricular cardiomyopathy in the genome aggregation database.

Hall CL, Sutanto H, Dalageorgou C, McKenna WJ, Syrris P, Futema M.

Eur J Hum Genet. 2018 Sep;26(9):1312-1318. doi: 10.1038/s41431-018-0169-4. Epub 2018 May 25.

20.

Arrhythmogenic right ventricular cardiomyopathy in Boxer dogs: the diagnosis as a link to the human disease.

Vischer AS, Connolly DJ, Coats CJ, Fuentes VL, McKenna WJ, Castelletti S, Pantazis AA.

Acta Myol. 2017 Sep 1;36(3):135-150. eCollection 2017 Sep.

21.

STING-Dependent Interferon-λ1 Induction in HT29 Cells, a Human Colorectal Cancer Cell Line, After Gamma-Radiation.

Chen J, Markelc B, Kaeppler J, Ogundipe VML, Cao Y, McKenna WG, Muschel RJ.

Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):97-106. doi: 10.1016/j.ijrobp.2018.01.091. Epub 2018 Feb 3.

PMID:
29619982
22.

Oxidative Phosphorylation as an Emerging Target in Cancer Therapy.

Ashton TM, McKenna WG, Kunz-Schughart LA, Higgins GS.

Clin Cancer Res. 2018 Jun 1;24(11):2482-2490. doi: 10.1158/1078-0432.CCR-17-3070. Epub 2018 Feb 2. Review.

23.

Lamin and the heart.

Captur G, Arbustini E, Bonne G, Syrris P, Mills K, Wahbi K, Mohiddin SA, McKenna WJ, Pettit S, Ho CY, Muchir A, Gissen P, Elliott PM, Moon JC.

Heart. 2018 Mar;104(6):468-479. doi: 10.1136/heartjnl-2017-312338. Epub 2017 Nov 25. Review.

PMID:
29175975
24.

Response by Andrews et al to Letter Regarding Article, "Electrical and Structural Substrate of Arrhythmogenic Right Ventricular Cardiomyopathy Determined Using Noninvasive Electrocardiographic Imaging and Late Gadolinium Magnetic Resonance Imaging".

Andrews CM, Srinivasan NT, Rosmini S, Bulluck H, Orini M, Jenkins S, Pantazis A, McKenna WJ, Moon JC, Lambiase PD, Rudy Y.

Circ Arrhythm Electrophysiol. 2017 Oct;10(10). pii: e005768. doi: 10.1161/CIRCEP.117.005768. No abstract available.

25.

Classification, Epidemiology, and Global Burden of Cardiomyopathies.

McKenna WJ, Maron BJ, Thiene G.

Circ Res. 2017 Sep 15;121(7):722-730. doi: 10.1161/CIRCRESAHA.117.309711. Review.

PMID:
28912179
26.

Electrical and Structural Substrate of Arrhythmogenic Right Ventricular Cardiomyopathy Determined Using Noninvasive Electrocardiographic Imaging and Late Gadolinium Magnetic Resonance Imaging.

Andrews CM, Srinivasan NT, Rosmini S, Bulluck H, Orini M, Jenkins S, Pantazis A, McKenna WJ, Moon JC, Lambiase PD, Rudy Y.

Circ Arrhythm Electrophysiol. 2017 Jul;10(7). pii: e005105. doi: 10.1161/CIRCEP.116.005105.

27.

TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy.

Pirovano G, Ashton TM, Herbert KJ, Bryant RJ, Verrill CL, Cerundolo L, Buffa FM, Prevo R, Harrap I, Ryan AJ, Macaulay V, McKenna WG, Higgins GS.

Br J Cancer. 2017 Aug 8;117(4):503-512. doi: 10.1038/bjc.2017.197. Epub 2017 Jul 4.

28.

18 F-fluoromisonidazole uptake in advanced stage non-small cell lung cancer: A voxel-by-voxel PET kinetics study.

McGowan DR, Macpherson RE, Hackett SL, Liu D, Gleeson FV, McKenna WG, Higgins GS, Fenwick JD.

Med Phys. 2017 Sep;44(9):4665-4676. doi: 10.1002/mp.12416. Epub 2017 Jul 21.

29.

Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation.

Castelletti S, Vischer AS, Syrris P, Crotti L, Spazzolini C, Ghidoni A, Parati G, Jenkins S, Kotta MC, McKenna WJ, Schwartz PJ, Pantazis A.

Int J Cardiol. 2017 Dec 15;249:268-273. doi: 10.1016/j.ijcard.2017.05.018. Epub 2017 May 10.

PMID:
28527814
30.

Depletion of signal recognition particle 72kDa increases radiosensitivity.

Prevo R, Tiwana GS, Maughan TS, Buffa FM, McKenna WG, Higgins GS.

Cancer Biol Ther. 2017 Jun 3;18(6):425-432. doi: 10.1080/15384047.2017.1323587. Epub 2017 May 11.

31.

Electrocardiographic differentiation of idiopathic right ventricular outflow tract ectopy from early arrhythmogenic right ventricular cardiomyopathy.

Novak J, Zorzi A, Castelletti S, Pantasis A, Rigato I, Corrado D, Mckenna W, Lambiase PD.

Europace. 2017 Apr 1;19(4):622-628. doi: 10.1093/europace/euw018.

32.

Comprehensive multi-modality imaging approach in arrhythmogenic cardiomyopathy-an expert consensus document of the European Association of Cardiovascular Imaging.

Haugaa KH, Basso C, Badano LP, Bucciarelli-Ducci C, Cardim N, Gaemperli O, Galderisi M, Habib G, Knuuti J, Lancellotti P, McKenna W, Neglia D, Popescu BA, Edvardsen T; EACVI Scientific Documents Committee, EACVI Board members and external reviewers; EACVI Scientific Documents Committee, EACVI Board members and external reviewers.

Eur Heart J Cardiovasc Imaging. 2017 Mar 1;18(3):237-253. doi: 10.1093/ehjci/jew229. Review.

33.

PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy.

Azad A, Yin Lim S, D'Costa Z, Jones K, Diana A, Sansom OJ, Kruger P, Liu S, McKenna WG, Dushek O, Muschel RJ, Fokas E.

EMBO Mol Med. 2017 Feb;9(2):167-180. doi: 10.15252/emmm.201606674.

34.

Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE.

Mont L, Pelliccia A, Sharma S, Biffi A, Borjesson M, Brugada Terradellas J, Carré F, Guasch E, Heidbuchel H, La Gerche A, Lampert R, McKenna W, Papadakis M, Priori SG, Scanavacca M, Thompson P, Sticherling C, Viskin S, Wilson M, Corrado D; Reviewers, Lip GY, Gorenek B, Blomström Lundqvist C, Merkely B, Hindricks G, Hernández-Madrid A, Lane D, Boriani G, Narasimhan C, Marquez MF, Haines D, Mackall J, Manuel Marques-Vidal P, Corra U, Halle M, Tiberi M, Niebauer J, Piepoli M.

Eur J Prev Cardiol. 2017 Jan;24(1):41-69. Epub 2016 Nov 4. Review. No abstract available.

PMID:
27815537
35.

Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE.

Mont L, Pelliccia A, Sharma S, Biffi A, Borjesson M, Terradellas JB, Carré F, Guasch E, Heidbuchel H, Gerche A, Lampert R, McKenna W, Papadakis M, Priori SG, Scanavacca M, Thompson P, Sticherling C, Viskin S, Wilson M, Corrado D, Lip GY, Gorenek B, Lundqvist CB, Merkely B, Hindricks G, Hernández-Madrid A, Lane D, Boriani G, Narasimhan C, Marquez MF, Haines D, Mackall J, Marques-Vidal PM, Corra U, Halle M, Tiberi M, Niebauer J, Piepoli M.

Europace. 2017 Jan;19(1):139-163. doi: 10.1093/europace/euw243. Epub 2016 Nov 4. No abstract available.

PMID:
27815371
36.

Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy.

Rosmini S, Biagini E, O'Mahony C, Bulluck H, Ruozi N, Lopes LR, Guttmann O, Reant P, Quarta CC, Pantazis A, Tome-Esteban M, Mckenna WJ, Rapezzi C, Elliott PM.

Heart. 2017 Feb 15;103(4):300-306. doi: 10.1136/heartjnl-2016-310138. Epub 2016 Oct 24.

PMID:
27798053
37.

Predictors of atrial fibrillation in hypertrophic cardiomyopathy.

Guttmann OP, Pavlou M, O'Mahony C, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, Garcia-Pavia P, McKenna WJ, Omar RZ, Elliott PM; Hypertrophic Cardiomyopathy Outcomes Investigators.

Heart. 2017 May;103(9):672-678. doi: 10.1136/heartjnl-2016-309672. Epub 2016 Oct 28.

PMID:
27794017
38.

Update on hypertrophic cardiomyopathy and a guide to the guidelines.

Sen-Chowdhry S, Jacoby D, Moon JC, McKenna WJ.

Nat Rev Cardiol. 2016 Nov;13(11):651-675. doi: 10.1038/nrcardio.2016.140. Epub 2016 Sep 29. Review.

PMID:
27681577
39.

Prognostic role and correlation of CA9, CD31, CD68 and CD20 with the desmoplastic stroma in pancreatic ductal adenocarcinoma.

Diana A, Wang LM, D'Costa Z, Azad A, Silva MA, Soonawalla Z, Allen P, Liu S, McKenna WG, Muschel RJ, Fokas E.

Oncotarget. 2016 Nov 8;7(45):72819-72832. doi: 10.18632/oncotarget.12022.

40.

Comments on potential health effects of MRI-induced DNA lesions: quality is more important to consider than quantity.

Hill MA, O'Neill P, McKenna WG.

Eur Heart J Cardiovasc Imaging. 2016 Nov;17(11):1230-1238. Epub 2016 Aug 22. Review.

41.

The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia.

Ashton TM, Fokas E, Kunz-Schughart LA, Folkes LK, Anbalagan S, Huether M, Kelly CJ, Pirovano G, Buffa FM, Hammond EM, Stratford M, Muschel RJ, Higgins GS, McKenna WG.

Nat Commun. 2016 Jul 25;7:12308. doi: 10.1038/ncomms12308.

42.

Prognostic value, localization and correlation of PD-1/PD-L1, CD8 and FOXP3 with the desmoplastic stroma in pancreatic ductal adenocarcinoma.

Diana A, Wang LM, D'Costa Z, Allen P, Azad A, Silva MA, Soonawalla Z, Liu S, McKenna WG, Muschel RJ, Fokas E.

Oncotarget. 2016 Jul 5;7(27):40992-41004. doi: 10.18632/oncotarget.10038.

43.

TBR1 regulates autism risk genes in the developing neocortex.

Notwell JH, Heavner WE, Darbandi SF, Katzman S, McKenna WL, Ortiz-Londono CF, Tastad D, Eckler MJ, Rubenstein JL, McConnell SK, Chen B, Bejerano G.

Genome Res. 2016 Aug;26(8):1013-22. doi: 10.1101/gr.203612.115. Epub 2016 Jun 20.

44.

The embryological basis of subclinical hypertrophic cardiomyopathy.

Captur G, Ho CY, Schlossarek S, Kerwin J, Mirabel M, Wilson R, Rosmini S, Obianyo C, Reant P, Bassett P, Cook AC, Lindsay S, McKenna WJ, Mills K, Elliott PM, Mohun TJ, Carrier L, Moon JC.

Sci Rep. 2016 Jun 21;6:27714. doi: 10.1038/srep27714.

45.

Personalized Radiation Oncology: Epidermal Growth Factor Receptor and Other Receptor Tyrosine Kinase Inhibitors.

Higgins GS, Krause M, McKenna WG, Baumann M.

Recent Results Cancer Res. 2016;198:107-22. doi: 10.1007/978-3-662-49651-0_5. Review.

PMID:
27318683
46.

The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cells.

Al-Assar O, Bittner MI, Lunardi S, Stratford MR, McKenna WG, Brunner TB.

Radiother Oncol. 2016 May;119(2):300-5. doi: 10.1016/j.radonc.2016.03.024. Epub 2016 May 28.

PMID:
27247056
47.

Inverted U-Shaped Relation Between the Risk of Sudden Cardiac Death and Maximal Left Ventricular Wall Thickness in Hypertrophic Cardiomyopathy.

O'Mahony C, Jichi F, Monserrat L, Ortiz-Genga M, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, McKenna WJ, Omar RZ, Elliott PM; Hypertrophic Cardiomyopathy Outcomes Investigators*.

Circ Arrhythm Electrophysiol. 2016 Jun;9(6). pii: e003818. doi: 10.1161/CIRCEP.115.003818.

PMID:
27217341
48.

Survival After Heart Transplantation in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.

DePasquale EC, Cheng RK, Deng MC, Nsair A, McKenna WJ, Fonarow GC, Jacoby DL.

J Card Fail. 2017 Feb;23(2):107-112. doi: 10.1016/j.cardfail.2016.04.020. Epub 2016 May 3.

PMID:
27154489
49.

ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer.

Wilson JM, Fokas E, Dutton SJ, Patel N, Hawkins MA, Eccles C, Chu KY, Durrant L, Abraham AG, Partridge M, Woodward M, O'Neill E, Maughan T, McKenna WG, Mukherjee S, Brunner TB.

Radiother Oncol. 2016 May;119(2):306-11. doi: 10.1016/j.radonc.2016.03.021. Epub 2016 Apr 23.

50.

The ventricular ectopic QRS interval (VEQSI): Diagnosis of arrhythmogenic right ventricular cardiomyopathy in patients with incomplete disease expression.

Bastiaenen R, Pantazis A, Gonna H, Chis-Ster I, Castelletti S, Batchvarov VN, Domenichini G, Coccolo F, Boriani G, McKenna WJ, Behr ER, Gallagher MM.

Heart Rhythm. 2016 Jul;13(7):1504-12. doi: 10.1016/j.hrthm.2016.03.039. Epub 2016 Mar 22.

PMID:
27016477

Supplemental Content

Loading ...
Support Center